Lara Meisner

Chief Legal Officer

Lara Meisner (Chief Legal Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Bicara Therapeutics Inc. (BCAX). The largest single filing was $499K of BCAX (33,807 sh × $14.75, as filed), executed Sep 29 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$499K

shares × price, as filed

Last traded

Sep 29 2025

Filed Oct 1 2025

Median ADV $19.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

BCAX

Bicara Therapeutics Inc. BCAX · 0 buys · 4 sells 4 filings

Recent filings

BCAXSALE Bicara Therapeutics Inc. View filing → $499K
33,807 sh × $14.75
Exec Sep 29 2025
Filed Oct 1 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $182K
15,829 sh × $11.49
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $165K
15,829 sh × $10.43
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET BCAXSALE Bicara Therapeutics Inc. View filing → $1.0M
79,146 sh across 2 lots
Exec Mar 14 2025
Filed Mar 18 2025 · 5:30 PM ET